Mirabella Financial Services LLP Lowers Holdings in CME Group Inc. $CME

Mirabella Financial Services LLP reduced its position in CME Group Inc. (NASDAQ:CME) by 89.3% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 5,398 shares of the financial services provider’s stock after selling 45,101 shares during the quarter. Mirabella Financial Services LLP’s holdings in CME Group were worth $1,494,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. AIA Group Ltd lifted its stake in CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock valued at $4,416,000 after buying an additional 2,510 shares in the last quarter. Lockheed Martin Investment Management Co. lifted its position in shares of CME Group by 34.1% in the first quarter. Lockheed Martin Investment Management Co. now owns 58,690 shares of the financial services provider’s stock valued at $15,570,000 after acquiring an additional 14,910 shares in the last quarter. Truist Financial Corp boosted its stake in shares of CME Group by 10.0% during the second quarter. Truist Financial Corp now owns 64,939 shares of the financial services provider’s stock valued at $17,898,000 after acquiring an additional 5,914 shares during the last quarter. Wealth Preservation Advisors LLC acquired a new stake in shares of CME Group during the first quarter valued at $75,000. Finally, Titleist Asset Management LLC purchased a new stake in CME Group during the 1st quarter worth about $284,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

CME stock opened at $273.19 on Friday. The firm has a market cap of $98.51 billion, a P/E ratio of 26.47, a price-to-earnings-growth ratio of 4.28 and a beta of 0.28. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $224.62 and a 1 year high of $290.79. The stock has a 50-day simple moving average of $271.55 and a 200-day simple moving average of $272.85.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter last year, the company earned $2.68 earnings per share. On average, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be issued a $1.25 dividend. The ex-dividend date is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s payout ratio is currently 48.45%.

Insiders Place Their Bets

In other news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,147 shares of company stock valued at $562,079 over the last ninety days. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the topic of a number of recent research reports. UBS Group reduced their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a report on Thursday, October 23rd. Rothschild & Co Redburn raised their target price on shares of CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research report on Thursday, November 6th. Barclays cut their price target on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a report on Wednesday, October 8th. Morgan Stanley lifted their price objective on CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a research report on Thursday, October 23rd. Finally, TD Cowen increased their price objective on shares of CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a report on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and an average price target of $287.71.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.